The histopathological effects of piracetam on carotis vasculary injury after temporary aneurysm clipping in a rat model
2013
0 görüntülenme
0 i̇ndirme
Danışman: Prof. Dr. Süleyman Baykal
Özet (EN)
İn this study we evaluated effects of piracetam on preventing or reducing vascular damage induced a temporary clipping . For this purpose, studies were performed on 35 female rat . Rats were divided into 5 groups. Temporary Yaşargil aneuyrsm clip straight into 4 groups performed to right A.carotis communis and the 4 and 5 groups in addition clipping piracetam medication adminestered for 3 days. Examined histopatologically classified as endothelial and vascular smooth muscle layer . As a result, which result from temporary aneurysm clipping endothelial and vascular smooth muscle layer to prevent or alleviate the damage was not statistically significant for the application of piracetam.Key words : Temporary aneurysm clip, A.Carotis communis, vasculary damage, piracetam , endothelial damage, vasculary smooth muscle damage
Yazar
Dr. Levent Gedikli
Bu Yayına Nasıl Atıf Yapılır
Levent Gedikli (Medical Specialty Thesis). The histopathological effects of piracetam on carotis vasculary injury after temporary aneurysm clipping in a rat model, 2013, Karadeniz Technical University.
Anahtar Kelimeler
Lisans
Tüm Hakları Saklıdır
Bu eser belirtilen lisans koşulları altında paylaşılmaktadır.
Karadeniz Technical University tezlerinden daha fazlası
- Traditional agricultural culture of Trabzon province in terms of folklore(2023)
- Prevalence and associated factors of tobacco use, alcohol consumption, alcohol use disorder among individuals aged 20 and above living in trabzon province(2025)
- Yaşlandırma Süresinin Zn-27Al-1Cu Alaşımının Yapı ve Mekanik Özelliklerine Etkisi(2016)
- Evaluation of the indications for the use of human albümin and fresh frozen plasma in our hospital(2024)
- Investigation of the effects of exogenously applied cysteine on gökçe and küsmen chickpea varieties under salt stress(2025)
- Investigation of autoantibodies in colorectal cancer patients and gastric cancer patients using the indirect immunofluorescence method(2025)
